February 14, 2018 / 12:14 PM / 3 days ago

BRIEF-Galmed Announces Arrive Study Data

Feb 14 (Reuters) - Galmed Pharmaceuticals Ltd:

* GALMED ANNOUNCES ARRIVE STUDY DATA

* TOP-LINE RESULTS FROM ARRIVE TRIAL DID NOT MEET ITS PRIMARY ENDPOINT

* ANNOUNCED TOP-LINE RESULTS FROM ARRIVE TRIAL, WHICH DID NOT MEET ITS PRIMARY ENDPOINT

* TOPLINE DATA FROM GALMED‘S PHASE IIB ARREST STUDY IS EXPECTED IN Q2 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below